For example, PRAME expression is strongly reduced in the melanocytes of benign nevi,11 but significantly higher in 88% of primary melanomas and 95% of metastatic melanomas.24 However, its expression appears to result from changes in the methylation status rather than chromosomal gains or deletions.24 The gene discussed is PRAME; the disease is metastatic melanoma.